Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional ...

Results showed that Active deep-TMS therapy significantly reduced "usual pain intensity" in patients with chronic peripheral neuropathic pain compared to sham treatment and improved symptoms of ...

Ltd. has announced the publication of Phase 2a clinical trial results for JX10 (TMS-007), a potential treatment for acute ischemic stroke, in a leading medical journal. The study demonstrated ...

TMS therapy does not require medications, sedation, or anesthesia, is very safe, and has very few side effects. TMS treatment sessions take place in the TMS Suite at the RNI. Patients undergoing the ...

This approval marks NeuroStar as the first and only transcranial magnetic stimulation (TMS) therapy cleared by the FDA for use in this younger demographic, expanding its indications to a fourth ...

BrainsWay Deep TMS is not currently cleared by the FDA for the safe or effective treatment of neuropathic pain. Additional outcomes from research conducted on these and other neuropathic pain patients ...

TMS (transcranial magnetic stimulation), is a safe, non-invasive, effective treatment option for individuals suffering from Major Depressive Disorder who have not seen satisfactory results from ...

BrainsWay (BWAY) announced the publication of positive feasibility clinical data evaluating the analgesic effects of deep transcranial magnetic ...